Technology Commercialization and Business Development
With more than $236 million in annual research expenditures, Temple University is generating cutting-edge discoveries that are advancing through an active commercialization program designed to accelerate technology development and new startup formation, including the recently launched startup fund Temple Ventures—Powered by Ben Franklin. Discoveries under development include phage technology to treat antibiotic-resistant bacteria, next-generation disinfectant technology, biomarkers for the early detection of traumatic brain injury, diagnostics for chronic obstructive pulmonary disorder (COPD), and therapeutics for HIV, cancer, arthritis and inflammatory bowel disease.
Over 13 active startup companies serve as important vehicles to advance Temple discoveries, including new therapies for heart failure, mobile expert systems for autism and a clinically-validated solution for remotely managing patients with COPD.
Temple stands ready to explore collaboration opportunities through the Office of Technology Commercialization and Business Development, an integrated hub for entrepreneurs and industry to discover their next partnership opportunity.